SEC Comment Letter 0000000000-24-008810 to DataMeds AI, Inc. (WGRX)
DataMeds AI, Inc.
Date: Aug. 1, 2024 · CIK: 0002030763 · Accession: 0000000000-24-008810
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280945
Letter
August 1, 2024 Tim Canning Chief Executive Officer Danam Health, Inc 3000 Bayport Drive Suite 950 Tampa, FL 33607 Re:Danam Health, Inc Registration Statement on Form S-1 Filed July 22, 2024 File No. 333-280945 Dear Tim Canning: Our initial review of your registration statement indicates that it fails to comply with the requirements of the Securities Act of 1933, the rules and regulations thereunder and the requirements of the form. More specifically, the registration statement does not include interim unaudited financials for the three months ended March 31, 2024. We will provide more detailed comments relating to your registration statement following our review of a substantive amendment that addresses this deficiency.
Please contact Rucha Pandit at 202-551-6022 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc:Kate Bechen
Show Raw Text
August 1, 2024
Tim Canning
Chief Executive Officer
Danam Health, Inc
3000 Bayport Drive
Suite 950
Tampa, FL 33607
Re:Danam Health, Inc
Registration Statement on Form S-1
Filed July 22, 2024
File No. 333-280945
Dear Tim Canning:
Our initial review of your registration statement indicates that it fails to comply with the
requirements of the Securities Act of 1933, the rules and regulations thereunder and the
requirements of the form. More specifically, the registration statement does not include interim
unaudited financials for the three months ended March 31, 2024.
We will provide more detailed comments relating to your registration statement following
our review of a substantive amendment that addresses this deficiency.
Please contact Rucha Pandit at 202-551-6022 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:Kate Bechen